title: [Exclusion causes to thrombolytic treatment in myocardial infarction].
abstract: BACKGROUND
  Only one third of patients who have suffered a myocardial infarction can benefit from thrombolytic treatment in the daily clinic practice. The aim of this study is to know the percentage of patients who were treated in a General Hospital and the main exclusion causes to receive thrombolytic treatment.
  
  
  METHODS
  A descriptive study in patients with infarction who were admitted to the Critical Care Unit of a 550 beds Hospital between September-95 and August-96.
  
  
  RESULTS
  188 patients were admitted with suspicion of myocardial infarction. The 50.53% of them received thrombolytic treatment. The main exclusion causes to receive this treatment were: delay of the patient (18.10%), normal ECG or descended ST (16.50%), contraindications (8%), patient's refusal to receive treatment (0.53%) an uncertain indication of therapy (6.40%).
  
  
  CONCLUSIONS
  A high percentage of patients received thrombolytic therapy, maybe because these drugs can be used until 12 hours the infarction and they haven't limit of age.
authors.affiliation: Unidad de Cuidados Intensivos, Complejo Hospitalario San Millán-San Pedro del Insalud, Logroño, La Rioja.
authors.forename: F J
authors.initials: FJ
authors.lastname: Ochoa Gómez
authors.forename: J M
authors.initials: JM
authors.lastname: Carpintero Escudero
authors.forename: E
authors.initials: E
authors.lastname: Ramalle-Gómara
authors.forename: V
authors.initials: V
authors.lastname: Lisa Catón
authors.forename: P
authors.initials: P
authors.lastname: Marco Aguilar
mesh_terms: D000368:Aged; D000075202:Contraindications; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D012189:Retrospective Studies; D015912:Thrombolytic Therapy / Q000706:statistics & numerical data*
vernacular_title: Causas de exclusión de tratamiento trombolítico en el infarto de miocardio.